Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer
Aptamers provide a potential source of alternative targeting molecules for existing antibody diagnostics and therapeutics. In this work, we selected novel DNA aptamers targeting the HER2 receptor by an adherent whole-cell SELEX approach. Individual aptamers were identified by next generation sequenc...
Saved in:
Main Authors: | Marlies Gijs (Author), Gregory Penner (Author), Garth B. Blackler (Author), Nathalie R.E.N. Impens (Author), Sarah Baatout (Author), André Luxen (Author), An M. Aerts (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer
by: Xiaolin Yu, et al.
Published: (2018) -
Aptamers' Potential to Fill Therapeutic and Diagnostic Gaps
by: Alfredo Berzal-Herranz, et al.
Published: (2024) -
The Potential Use of Aptamers in The Process of Drug Development
by: Tooba Gholikhani, et al.
Published: (2021) -
Aptamer-Based Diagnostics and Therapeutics
by: Sarah Shigdar
Published: (2019) -
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers
by: Dario Ruiz-Ciancio, et al.
Published: (2024)